HomeRAPT • NASDAQ
Rapt Therapeutics Inc
add
$9.73
1.78%
After Hours:(3.80%)-0.37
$9.36
Closed: Jun 26, 6:48:00 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 19.27M | -40.76% |
Net income | -17.17M | 43.76% |
Net profit margin | — | — |
Earnings per share | -0.64 | 89.87% |
EBITDA | -19.01M | 40.96% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 179.28M | 26.63% |
Total assets | 187.57M | 20.38% |
Total liabilities | 10.20M | -59.18% |
Total equity | 177.37M | — |
Shares outstanding | 16.54M | — |
Price to book | 0.89 | — |
Return on assets | -22.51% | — |
Return on capital | -25.65% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -17.17M | 43.76% |
Cash from operations | -52.41M | -93.52% |
Cash from investing | -57.06M | -459.19% |
Cash from financing | — | — |
Net change in cash | -109.48M | -4,966.08% |
Free cash flow | -46.49M | -140.80% |
Previous close
$9.56
Day range
$8.83 - $9.76
Year range
$5.67 - $30.60
Market cap
160.90M USD
Avg Volume
115.72K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Headquarters
Website
Employees
67
